Moderna, Inc. revenue breakdown overview

Moderna, Inc. revenue for the last year amounted to 3.24 B USD, the most of which — 3.24 B USD — came from its highest performing source at the moment, Messenger RNA (mRNA) Medicines, the year earlier bringing 6.85 B USD. The greatest contribution to the revenue figure was made by United States — last year it brought Moderna, Inc. 1.78 B USD, and the year before that — 1.90 B USD.